GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Total Liabilities

Hamilton Thorne (TSX:HTL) Total Liabilities : C$58.8 Mil (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Total Liabilities?

Hamilton Thorne's Total Liabilities for the quarter that ended in Sep. 2024 was C$58.8 Mil.

Hamilton Thorne's quarterly Total Liabilities increased from Mar. 2024 (C$58.99 Mil) to Jun. 2024 (C$61.28 Mil) but then declined from Jun. 2024 (C$61.28 Mil) to Sep. 2024 (C$58.79 Mil).

Hamilton Thorne's annual Total Liabilities increased from Dec. 2021 (C$24.46 Mil) to Dec. 2022 (C$41.36 Mil) and increased from Dec. 2022 (C$41.36 Mil) to Dec. 2023 (C$59.87 Mil).


Hamilton Thorne Total Liabilities Historical Data

The historical data trend for Hamilton Thorne's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Total Liabilities Chart

Hamilton Thorne Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.32 24.01 24.46 41.36 59.87

Hamilton Thorne Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.82 59.87 58.99 61.28 58.79

Hamilton Thorne Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hamilton Thorne's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=22.849+(29.594+0.308
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+7.119+0)
=59.9

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=146.606-86.736
=59.9

Hamilton Thorne's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=25.248+(26.457+0.433
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+6.648+0)
=58.8

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=147.269-88.485
=58.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamilton Thorne Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamilton Thorne Business Description

Traded in Other Exchanges
Address
100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Executives
Adam Stettner Director or Senior Officer of 10% Security Holder
David Greenhouse Director or Senior Officer of 10% Security Holder
Inc. Awm Investment Company 10% Security Holder
Robert J Potter Director
David Wolf Director, Senior Officer
Karen Firestone Director
Diarmaid Hugh Douglas-hamilton Director, Senior Officer
Blair Driscoll 10% Security Holder
Merrilyn Joy Driscoll 10% Security Holder
Sean Driscoll 10% Security Holder
Fax Capital Corp. 10% Security Holder
Fax Investments Inc. 10% Security Holder
Federated Capital Corp. 10% Security Holder
Feng Han Director
Keith Edwards Senior Officer

Hamilton Thorne Headlines

No Headlines